The research aims to explore how cell-free RNA profiles can differentiate cancer patients from controls.
Analyzed blood plasma samples for cfRNA alterations
Classified samples based on identified RNA profiles
Compared profiles between cancer patients and controls
Observed significant variability in cfRNA profiles among cancer patients
Identified specific RNA patterns that predict cancer presence
Demonstrated potential for using cfRNA as a classification biomarker
Abstract
Our findings demonstrate substantial heterogeneity in cell-free RNA alterations among cancer patients and propose that patient-specific changes can be exploited for classification.